当前位置：
X-MOL 学术
›
Diabetes Metab.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Associations of type 2 diabetes and the risk of migraine in Chinese populations
Diabetes & Metabolism ( IF 7.2 ) Pub Date : 2024-01-23 , DOI: 10.1016/j.diabet.2024.101518 Jielong Wu , Jie Fang , Xiaodong Yuan , Lingshan Ma , Liangcheng Zheng , Qing Lin , Xingkai An , Zhanxiang Wang , Qilin Ma
Diabetes & Metabolism ( IF 7.2 ) Pub Date : 2024-01-23 , DOI: 10.1016/j.diabet.2024.101518 Jielong Wu , Jie Fang , Xiaodong Yuan , Lingshan Ma , Liangcheng Zheng , Qing Lin , Xingkai An , Zhanxiang Wang , Qilin Ma
We aimed to explore the relationship between type 2 diabetes mellitus (T2DM) and the incidence rate of migraine in a Chinese population, and analyze the clinical characteristics of migraine patients with T2DM. Data on the study cohort of 9873 individuals were obtained from the China Health and Retirement Longitudinal Study (CHARLS). The incidence rate of migraine from 2015 to 2018 was assessed. The Cox proportional hazards model was used to estimate hazard ratios (HRs) and their 95% confidence intervals (CIs) for the relationship between T2DM and the incidence of migraine. In addition, a cross-sectional study including 168 migraine patients was conducted in Xiamen, China. Migraine patients were grouped according to their T2DM status. Multivariable linear regression models were used to estimate βs and their 95% CIs for the relationship between migraine characteristics and T2DM. The cumulative incidence rate of migraine from 2015 to 2018 in the T2DM group and control group was 7.26% [6.04%.8.65%] and 8.91% [8.27%.9.58%], respectively. The risk of migraine in patients with T2DM was reduced by 21% (HR 0.79 [0.65;0.95]) compared to patients with no T2DM after adjustment for confounders. The cross-sectional study showed that the presence of T2DM significantly reduced migraine frequency and relieved migraine intensity. This was the first study to validate that T2DM reduced the risk of migraine in a Chinese population cohort. Patients with migraine and T2DM may experience significant relief from their headache symptoms. Carrying out relevant mechanistic research may help to identify new targets for migraine treatment and contribute to further understanding the impact of T2DM or related metabolic disorders on an individual's health.
更新日期：2024-01-23
京公网安备 11010802027423号